Literature DB >> 16423050

CD45: all is not yet crystal clear.

Nick Holmes1.   

Abstract

CD45 has been recognized as an important player in regulating signalling in lymphocytes. However, compared with tyrosine kinases, phosphatases are still poorly understood in terms of the details of their specificity and regulation. Here, the recent progress in understanding the biology of the first recognized receptor tyrosine phosphatase, CD45, is reviewed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16423050      PMCID: PMC1782222          DOI: 10.1111/j.1365-2567.2005.02265.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  104 in total

1.  Domain organization of the extracellular region of CD45.

Authors:  A Symons; A C Willis; A N Barclay
Journal:  Protein Eng       Date:  1999-10

2.  Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease.

Authors:  C Kung; J T Pingel; M Heikinheimo; T Klemola; K Varkila; L I Yoo; K Vuopala; M Poyhonen; M Uhari; M Rogers; S H Speck; T Chatila; M L Thomas
Journal:  Nat Med       Date:  2000-03       Impact factor: 53.440

3.  Cell-specific glycoforms of sialoadhesin and CD45 are counter-receptors for the cysteine-rich domain of the mannose receptor.

Authors:  L Martínez-Pomares; P R Crocker; R Da Silva; N Holmes; C Colominas; P Rudd; R Dwek; S Gordon
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

4.  Characterization of the interaction between galectin-1 and lymphocyte glycoproteins CD45 and Thy-1.

Authors:  A Symons; D N Cooper; A N Barclay
Journal:  Glycobiology       Date:  2000-06       Impact factor: 4.313

5.  Receptor-like protein tyrosine phosphatase alpha homodimerizes on the cell surface.

Authors:  G Jiang; J den Hertog; T Hunter
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

6.  Dimerization inhibits the activity of receptor-like protein-tyrosine phosphatase-alpha.

Authors:  G Jiang; J den Hertog; J Su; J Noel; J Sap; T Hunter
Journal:  Nature       Date:  1999-10-07       Impact factor: 49.962

7.  A supramolecular basis for CD45 tyrosine phosphatase regulation in sustained T cell activation.

Authors:  K G Johnson; S K Bromley; M L Dustin; M L Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

8.  Molecular basis of antigenic differences between the RT7 alleles of rat CD45.

Authors:  A Symons; A N Barclay
Journal:  Immunogenetics       Date:  2000-07       Impact factor: 2.846

9.  CD45-associated protein is not essential for the regulation of antigen receptor-mediated signal transduction.

Authors:  C Kung; M Okumura; J R Seavitt; M E Noll; L S White; J T Pingel; M L Thomas
Journal:  Eur J Immunol       Date:  1999-12       Impact factor: 5.532

10.  Biochemical and functional analysis of mice deficient in expression of the CD45-associated phosphoprotein LPAP.

Authors:  I Ding; E Bruyns; P Li; D Magada; M Paskind; L Rodman; T Seshadri; D Alexander; T Giese; B Schraven
Journal:  Eur J Immunol       Date:  1999-12       Impact factor: 5.532

View more
  29 in total

1.  Overexpression of CD45RA isoforms in carriers of the C77G mutation leads to hyporeactivity of CD4+CD25highFoxp3+ regulatory T cells.

Authors:  C Pokoyski; T Lienen; S Rother; E Schock; A Plege-Fleck; R Geffers; R Schwinzer
Journal:  Genes Immun       Date:  2015-09-10       Impact factor: 2.676

2.  Differential impact of the CD45 juxtamembrane wedge on central and peripheral T cell receptor responses.

Authors:  Michelle L Hermiston; Julie Zikherman; Allison L Tan; Viola C Lam; Nicole M Cresalia; Nir Oksenberg; Nira Goren; David Brassat; Jorge R Oksenberg; Arthur Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-07       Impact factor: 11.205

3.  A unique secreted adenovirus E3 protein binds to the leukocyte common antigen CD45 and modulates leukocyte functions.

Authors:  Mark Windheim; Jennifer H Southcombe; Elisabeth Kremmer; Lucy Chaplin; Doris Urlaub; Christine S Falk; Maren Claus; Janine Mihm; Myles Braithwaite; Kevin Dennehy; Harald Renz; Martina Sester; Carsten Watzl; Hans-Gerhard Burgert
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

4.  Bone marrow aspirate and biopsy: a pathologist's perspective. II. interpretation of the bone marrow aspirate and biopsy.

Authors:  Roger S Riley; David Williams; Micaela Ross; Shawn Zhao; Alden Chesney; Bradly D Clark; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

5.  Receptor type protein tyrosine phosphatases (RPTPs) - roles in signal transduction and human disease.

Authors:  Yiru Xu; Gary J Fisher
Journal:  J Cell Commun Signal       Date:  2012-08-01       Impact factor: 5.782

6.  Drinking water with red beetroot food color antagonizes esophageal carcinogenesis in N-nitrosomethylbenzylamine-treated rats.

Authors:  John F Lechner; Li-Shu Wang; Claudio M Rocha; Bethany Larue; Cassandra Henry; Colleen M McIntyre; Kenneth M Riedl; Steven J Schwartz; Gary D Stoner
Journal:  J Med Food       Date:  2010-06       Impact factor: 2.786

Review 7.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

Review 8.  CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells.

Authors:  Michelle L Hermiston; Julie Zikherman; Jing W Zhu
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

9.  Regulation of CD45 alternative splicing by heterogeneous ribonucleoprotein, hnRNPLL.

Authors:  Shalini Oberdoerffer; Luis Ferreira Moita; Daniel Neems; Rui P Freitas; Nir Hacohen; Anjana Rao
Journal:  Science       Date:  2008-07-10       Impact factor: 47.728

10.  TOM1L is involved in a novel signaling pathway important for the IL-2 production in Jurkat T cells stimulated by CD3/CD28 co-ligation.

Authors:  Ahmed Elmarghani; Hanan Abuabaid; Peter Kjellen
Journal:  Mediators Inflamm       Date:  2010-02-21       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.